Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) variants have been reported to be resistant to several neutralizing antibodies (NAbs) targeting Receptor Binding Domain (RBD) and N Terminal Domain (NTD) of spike (S) protein and thus inducing immune escape. However, fewer studies were car...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xingsu, Fan, Linlin, Zheng, Binyang, Li, Haoze, Wang, Jiwei, Zhang, Li, Li, Jingxin, Zhu, Fengcai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225664/
https://www.ncbi.nlm.nih.gov/pubmed/35417303
http://dx.doi.org/10.1080/21645515.2022.2055373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225664/
https://www.ncbi.nlm.nih.gov/pubmed/35417303
http://dx.doi.org/10.1080/21645515.2022.2055373

Ejemplares similares